Mistry PK - Search Results

1

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.

Mistry PK, Balwani M, Baris HN, Turkia HB, Burrow TA, Charrow J, Cox GF, Danda S, Dragosky M, Drelichman G, El-Beshlawy A, Fraga C, Freisens S, Gaemers S, Hadjiev E, Kishnani PS, Lukina E, Maison-Blanche P, Martins AM, Pastores G, Petakov M, Peterschmitt MJ, Rosenbaum H, Rosenbloom B, Underhill LH, Cox TM. Mistry PK, et al. Blood Cells Mol Dis. 2019 Jul;77:101-102. doi: 10.1016/j.bcmd.2019.04.003. Epub 2019 Apr 9. Blood Cells Mol Dis. 2019. PMID: 31029022 No abstract available.

2

Genetic diagnosis of Gaucher's disease.

Mistry PK, Smith SJ, Ali M, Hatton CS, McIntyre N, Cox TM. Mistry PK, et al. Lancet. 1992 Apr 11;339(8798):889-92. doi: 10.1016/0140-6736(92)90928-v. Lancet. 1992. PMID: 1348297

3

Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.

Mistry PK, Davies S, Corfield A, Dixon AK, Cox TM. Mistry PK, et al. Q J Med. 1992 Jul;83(303):541-6. Q J Med. 1992. PMID: 1484931

4

The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.

Mistry PK, Cox TM. Mistry PK, et al. J Med Genet. 1993 Nov;30(11):889-94. doi: 10.1136/jmg.30.11.889. J Med Genet. 1993. PMID: 8301642 Free PMC article. Review. No abstract available.

5

Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease.

Mistry PK, Wraight EP, Cox TM. Mistry PK, et al. Lancet. 1996 Dec 7;348(9041):1555-9. doi: 10.1016/S0140-6736(96)04451-0. Lancet. 1996. PMID: 8950883

6

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A. Charrow J, et al. Arch Intern Med. 2000 Oct 9;160(18):2835-43. doi: 10.1001/archinte.160.18.2835. Arch Intern Med. 2000. PMID: 11025794

7

Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease.

Sirrs S, Irving J, McCauley G, Gin K, Munt B, Pastores G, Mistry P. Sirrs S, et al. J Inherit Metab Dis. 2002 May;25(2):131-2. doi: 10.1023/a:1015680827730. J Inherit Metab Dis. 2002. PMID: 12118528

8

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A. Weinreb NJ, et al. Am J Med. 2002 Aug 1;113(2):112-9. doi: 10.1016/s0002-9343(02)01150-6. Am J Med. 2002. PMID: 12133749

9

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ. Charrow J, et al. J Pediatr. 2004 Jan;144(1):112-20. doi: 10.1016/j.jpeds.2003.10.067. J Pediatr. 2004. PMID: 14722528 Review. No abstract available.

10

Therapeutic goals in the treatment of Gaucher disease.

Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szymańska A. Pastores GM, et al. Among authors: mistry pk. Semin Hematol. 2004 Oct;41(4 Suppl 5):4-14. doi: 10.1053/j.seminhematol.2004.07.009. Semin Hematol. 2004. PMID: 15468045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters